Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

PrimaryBid.com Offer

19 Mar 2019 16:31

RNS Number : 3495T
Highlands Natural Resources PLC
19 March 2019
Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

Β 

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF HIGHLANDS NATURAL RESOURCES PLC.

Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Β 

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRNΒ 779021)

Β 

19 March 2019

Β 

Highlands Natural Resources plc

("Highlands" or the "Company") (LSE: HNR.L)

Β 

PrimaryBid.com Offer

Fundraising to establish an organic cannabidiol operation

Β 

Β 

At 4.30 p.m. on 19Β March 2019, Highlands,Β the London-listed natural resources company, issued an announcement through RNS (the "Announcement") of a fundraising to raise a minimum of Β£1.27 million via a subscription for ordinary shares of 1 pence each and an offer for ordinary shares via PrimaryBid.com (the "Offer") at a price of 8.5 pence (the "Issue Price"), being a discount of approximately 20.9% per cent to the closing mid-price onΒ 18 March 2019.

Β 

The funds raised by way of the Offer will be used to establish an organic, vertically integrated cannabidiol ("CBD") operation in Colorado, in the United States, through a newly established and wholly-owned Highlands subsidiary, Zoetic Organics, further details of which are set out in the Announcement which should be read in its entirety.

Β 

Offer

Β 

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

Β 

The Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors from 4.31 p.m. onΒ 19 March 2019 to 9.00 p.m. on 19 March 2019. The Offer may close early if it is oversubscribed.

Β 

Subscriptions under the Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com) with any investment request over Β£50,000 first requiring consultation with the Company.

Β 

No commission is charged to investors on applications to participate in the Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

Β 

For further information on PrimaryBid.com or the procedure for applications under the Offer, visitΒ www.PrimaryBid.comΒ or call PrimaryBid.com on +44 20 3026 4750.Β 

Β 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rankΒ pari passuΒ in all respects with the Company's existing Ordinary Shares.

Β 

Defined terms in this announcement will have the same meaning as those in the Company's announcement of 4:30 p.m. today unless otherwise so defined.

Β 

Enquiries

Β 

Highlands Natural Resources plc +1 (0) 303 322 1066

Robert Price

Β 

PrimaryBid Limited +44 20 3026 4750

Robert Beenstock

Β 

Cantor Fitzgerald Europe +44 (0) 20 7894 7000

Nick Tulloch

David Porter

Keith, Bayley, Rogers & Co. Limited +44 207 464 4098

Brinsley Holman

Newgate Communications +44 (0) 20 3757 6880

Elisabeth Cowell

Fiona Norman

Β 

Details of the Offer

Β 

The Company highly values its retail investor base, which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

Β 

Retail and other investors may participate in the Offer of New Ordinary Shares on a first come, first served basis, exclusively through PrimaryBid.com.

Β 

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of aΒ prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

Β 

There is a minimum subscription of Β£100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com. This allocation will be filled on a "first come first served" basis.

Β 

Any investment request in excess of Β£50,000 will require the Company's consent and may be subject to scale back.

Β 

For further details please refer to the PrimaryBid.com website atΒ www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Β 

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

Β 

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCUKANRKAAOAAR
Date   Source Headline
24th Nov 20209:00 amRNSPrice Monitoring Extension
24th Nov 20207:00 amRNSLandmark agreement to distribute products
19th Nov 20207:00 amRNSTrading Update
16th Nov 202011:06 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
16th Nov 20209:05 amRNSSecond Price Monitoring Extn
16th Nov 20209:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSUpdate on Director Share Purchases
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSUpdate on Sale of DTU and Kansas Nitrogen Assets
29th Oct 20207:00 amRNSHolding(s) in Company
28th Oct 20204:00 pmRNSDirectors’ Share Purchases and Share Options
28th Oct 20203:30 pmRNSResult of AGM
28th Oct 20201:30 pmRNSExercise of Share Options
28th Oct 20207:00 amRNSTrading Update
21st Oct 202011:00 amRNSHolding(s) in Company
12th Oct 20204:40 pmRNSSecond Price Monitoring Extn
12th Oct 20204:35 pmRNSPrice Monitoring Extension
9th Oct 202011:05 amRNSSecond Price Monitoring Extn
9th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNotice of AGM & Investor Presentation
1st Oct 20204:40 pmRNSSecond Price Monitoring Extn
1st Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20205:40 pmRNSFinal Results for the year ended 31 March 2020
30th Sep 20207:00 amRNSPreliminary Results for the year to 31 March 2020
16th Sep 202010:35 amRNSHolding(s) in Company
11th Sep 20202:05 pmRNSSecond Price Monitoring Extn
11th Sep 20202:00 pmRNSPrice Monitoring Extension
10th Sep 20207:30 amRNSSecond International Distribution Contract Signed
2nd Sep 20207:00 amRNSSale of Colorado Oil and Gas Interests
20th Aug 20204:41 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
20th Aug 20202:00 pmRNSHolding(s) in Company
18th Aug 20202:05 pmRNSSecond Price Monitoring Extn
18th Aug 20202:01 pmRNSPrice Monitoring Extension
17th Aug 20205:30 pmRNSHolding(s) in Company
14th Aug 20202:30 pmRNSHolding(s) in Company
7th Aug 20203:02 pmRNSHolding(s) in Company
7th Aug 20202:05 pmRNSSecond Price Monitoring Extn
7th Aug 20202:00 pmRNSPrice Monitoring Extension
6th Aug 202011:05 amRNSSecond Price Monitoring Extn
6th Aug 202011:00 amRNSPrice Monitoring Extension
5th Aug 20204:00 pmRNSHolding(s) in Company
3rd Aug 20207:00 amRNSUpdate on Sale of DTU and Kansas Nitrogen Assets
23rd Jul 20202:32 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSHemp Seed Update
8th Jul 20207:00 amRNSUpdate on Sale of DTU & Kansas Nitrogen Assets
6th Jul 20207:00 amRNSFirst International Distribution Contract
30th Jun 20206:00 pmRNSTotal Voting Rights & Reporting Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.